Drug Antitrust · Claims Closed

West Virginia Lipitor Consumer Settlement Claims Closed

Published June 13, 2025
Updated July 29, 2026

West Virginia reserved $3,819,250 for consumers who allegedly overpaid for branded Lipitor before generic competition; the July 2025 claim period is closed.

West Virginia Lipitor Consumer Settlement Claims Closed

Current Status

The consumer claim deadline passed July 28, 2025. West Virginia announced distributions to government entities in May 2025, but the official consumer claim site has not posted a public date confirming that individual consumer payments were issued.

StatusClaims closed; consumer payment update not posted
Claim DeadlineJuly 28, 2025 (Passed)
BenefitUp to $599 for an approved consumer claim
Proof RequiredReceipts were not required

What Was This Matter About?

West Virginia alleged that Pfizer- and Ranbaxy-related companies delayed lower-cost generic competition for Lipitor, causing consumers and public entities to pay more. The settling companies did not admit liability.

Who Could File?

The consumer process covered people who bought branded Lipitor in West Virginia and paid some or all of the cost, including a copay or other out-of-pocket amount, from March 24, 2010 through November 30, 2011.

What Happens Next?

New claims are not accepted. Former claimants should rely on the official consumer site for claim-processing or payment updates.

Official Information

Review notices and documents on the West Virginia Lipitor Claim website.

Consumer Fund $3,819,250
Matter West Virginia Lipitor antitrust settlements
Administrator ILYM Group
Jurisdiction State of West Virginia
Current Milestone Claims closed; consumer distribution update unavailable
Official Website West Virginia Lipitor Claim
For more class actions, recalls, and refunds, keep scrolling below.

More Consumer Settlements